| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Intellia Therapeutics, Inc.: Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates | 20 | GlobeNewswire (USA) | ||
| Mo | Intellia Therapeutics, Inc.: Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024 | 18 | GlobeNewswire (USA) | ||
| 25.04. | Intellia (NTLA) to Report Q1 Earnings: What's in the Cards? | 22 | Zacks | ||
| 15.04. | Intellia Therapeutics, Inc. - 8-K, Current Report | 32 | SEC Filings | ||
| 28.03. | Better Cathie Wood Stock: Moderna vs. Intellia | 78 | The Motley Fool | ||
| 22.03. | Intellia opts out of hemophilia pact with Regeneron | 21 | Seeking Alpha | ||
| 22.03. | Intellia opts out of hemophilia gene editing work with Regeneron | 14 | FierceBiotech | ||
| 22.03. | Intellia Therapeutics, Inc. - 8-K, Current Report | 8 | SEC Filings | ||
| 19.03. | Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study | 9 | Zacks | ||
| 18.03. | Intellia stock PT raised to $99 at Brookline Capital on revenue potential | 13 | Investing.com | ||
| 18.03. | Intellia begins phase 3 trial for CRISPR therapy NTLA-2001 | 9 | Investing.com | ||
| 18.03. | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy | 166 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based... ► Artikel lesen | |
| 09.03. | Is Intellia Therapeutics Stock a Buy Now? | 48 | The Motley Fool | ||
| 06.03. | Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst | 13 | The Motley Fool | ||
| 04.03. | Global Software Engineering Company, Intellias, Strengthens Its Retail Offer, Adding 40 New Clients in 2023 and Opening Up New International Markets | 267 | Business Wire | Intellias, the global software engineering and digital consultancy company, has announced that it has consolidated its retail growth, expanding account growth by +40% in the last 12 months.
As... ► Artikel lesen | |
| 23.02. | Intellia Therapeutics, Inc. (NTLA) Q4 2023 Earnings Call Transcript | 27 | Insider Monkey | ||
| 23.02. | Intellia (NTLA) Beats on Q4 Earnings, Provides Pipeline Update | 27 | Zacks | ||
| 23.02. | Goldman cuts Intellia stock to Neutral given 'competitive and commercial dynamics' | 33 | Investing.com | ||
| 23.02. | '2024 will be a year of execution for Intellia' - Evercore | 24 | Investing.com | ||
| 23.02. | Citi maintains neutral stance on Intellia shares with $31 target | 10 | Investing.com |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.528 |
| NEL | 1.483 |
| APPLE | 1.392 |
| BAYER | 1.300 |
| BYD | 1.295 |
| SUPER MICRO COMPUTER | 1.209 |
| DEUTSCHE BANK | 1.113 |
| TUI | 1.085 |
| NVIDIA | 1.050 |
| PLUG POWER | 927 |
| DAIMLER TRUCK | 881 |
| TESLA | 881 |
| MERCEDES-BENZ | 811 |
| RWE | 788 |
| RHEINMETALL | 775 |
| AURUBIS | 737 |
| RENK GROUP | 699 |
| VOLKSWAGEN | 689 |
| DEUTSCHE LUFTHANSA | 683 |
| COMMERZBANK | 674 |
| AMAZON | 642 |
| SIEMENS ENERGY | 631 |
| AIXTRON SE | 598 |
| SIXT SE VZ | 584 |
| NOVO NORDISK | 546 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
